✦ LIBER ✦

Mutation analysis of hepatitis B virus promoters in chronically infected children

✍ Scribed by J. W. Sohn; C. W. Lee; J. H. Lee; K. C. Lee; C. S. Son; J. W. Lee; Y. M. Ha-Lee

Book ID: 106210399
Publisher: Springer Vienna
Year: 2005
Tongue: English
Weight: 236 KB
Volume: 150
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s00705-005-0501-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis B virus i

Treatment of chronic hepatitis B virus infection in children

✍ David E. Brumbaugh; Ronald J. Sokol 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 264 KB

Hepatitis B virus mutation in children

✍ Mei-Hwei Chang 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 449 KB

Complete hepatitis B virus genome analys

Complete hepatitis B virus genome analysis in chronically infected children before and during lamivudine treatment

✍ Isabel Conzelmann; Philip Wintermeyer; Stefan Wirth; Robert Radke; Patrick Gerne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

It is well established that during lamivudine treatment, mutations emerge within the polymerase gene but there is little information about the selection of other mutations in the whole hepatitis B virus (HBV) genome. The aim of this study was to investigate whether mutations outside this region are

Mutations in the core promoter region of

Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B

✍ Kurosaki, Masayuki; Enomoto, Nobuyuki; Asahina, Yasuhiro; Sakuma, Ikuo; Ikeda, T 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

The core promoter region of hepatitis B virus genomes regulates transcription of the precore and pregenomic mRNAs encoding hepatitis B e antigen (HBeAg) and core antigen that contain target epitopes for cytotoxic T lymphocytes. The prevalence and clinical significance of mutations in this region wer

Acyclovir in chronic hepatitis B virus i

Acyclovir in chronic hepatitis B virus infection

✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti

AFP in chronic hepatitis B virus infection

✍ Yun-Fan Liaw; Anna Lok 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a